跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7 条关于
“NovaBridge”
全部
7
临床试验
0
药物
0
机构
0
资讯
7
10个月前
NovaBridge Subsidiary Visara Assigns VIS-101 License to Everest Medicines for Asian Markets
上个月
NovaBridge to Report First Half 2026 Results and Corporate Update on August 20
11个月前
I-Mab Announces Strategic Transformation to NovaBridge Biosciences with Hong Kong IPO Plans and VIS-101 Acquisition
6个月前
NovaBridge's VIS-101 Shows Promising Phase 2a Results in Wet AMD with Potential Best-in-Class Durability
9个月前
NovaBridge's Ragistomig Shows Promise in Checkpoint Inhibitor-Resistant Cancers with New Q6W Dosing Schedule
8个月前
ABL Bio Secures $55 Million from Eli Lilly for Grabody Bispecific Antibody Platform Development
7个月前
CD137 Targeted Therapies Advance with 90 Clinical Trials Spanning Multiple Cancer Types